Numerate Raises 5.5 Million Series B
16 Mar 2009
Numerate Inc., a San Bruno, Calif.-based drug engineering company, has raised around $5.5 million in Series B funding, according to a regulatory filing. Backers include Foundation Capital and Lanza TechVentures.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.